First phase of a long-term collaboration set to improve the research experience by integrating flagship solutions ChemDraw and Reaxys New York, May 8, 2018 Elsevier, the information analytics business specializing in science and health, has today announced a strategic collaboration with PerkinElmer. The first phase of this collaboration will see the integration of Elsevier’s flagship chemistry... Read more
April 10, 2018 at 8:15 AM EDT PDF Version First Personal Genomics Product Will Focus on 59 Genes Identified by the American College of Medical Genetics and Genomics (ACMG) as Highly Penetrant WALTHAM, Mass.–(BUSINESS WIRE)–Apr. 10, 2018– PerkinElmer, Inc. (NYSE: PKI), a global leader committed to innovating for a healthier world, today announced a collaboration with Helix, a personal genomics company,... Read more
April 5, 2018 at 8:15 AM EDT PDF Version WALTHAM, Massachusetts – April 5, 2018 – PerkinElmer, Inc., a global leader committed to innovating for a healthier world, today announced that Parent Project Muscular Dystrophy (PPMD) has selected the Company to provide genetic testing for its Decode Duchenne program. Duchenne muscular dystrophy (Duchenne) is the most common genetic disorder diagnosed in... Read more
April 4, 2018 at 4:15 PM EDT PDF Version WALTHAM, Mass.–(BUSINESS WIRE)–Apr. 4, 2018– PerkinElmer, Inc. (NYSE: PKI), a global leader committed to innovating for a healthier world, announced today that it has priced an offering of €300 million aggregate principal amount of 0.600% Senior Notes due 2021 at an issue price of 99.950% of the principal... Read more
NEW DELHI–(BUSINESS WIRE)–The Biotechnology Industry Research Assistance Council (BIRAC) celebrated its 6th Foundation Day on Tuesday in New Delhi. The event, aptly themed ‘Sustaining Innovation: A Market Driven Pathway’, was presided over by the Hon’ble Minister of State for Science and Technology & Earth Sciences, Dr Harsh Vardhan, Prof. Ashutosh Sharma, Secretary, Department of Biotechnology... Read more
Download PDF Read more
WALTHAM, Mass.–(BUSINESS WIRE)– PerkinElmer, Inc. (NYSE: PKI), a global leader committed to innovating for a healthier world, today announced that the Company will present at the Cowen and Company 38th Annual Health Care Conference on Monday, March 12, 2018 at 2:50 pm ET at the Marriott Copley Place in Boston. Robert F. Friel, PerkinElmer’s chairman... Read more
Charles Gross , Benzinga Staff Writer February 25, 2018 5:47pm RHS Limited (ASX: RHS) is pleased to announce that it has entered into a binding Scheme Implementation Agreement (“SIA”) with PerkinElmer, Inc. (“PerkinElmer”) PKI 0.29% for the acquisition by PerkinElmer of all of the issued share capital of RHS by way of a Scheme of Arrangement (“Scheme”) for $0.28 per share. The... Read more
–New Certified Service Provider and Compatible Partnership Programs will provide an extended ecosystem of reliable NGS workflow solutions for 10x Genomics’ customers– PLEASANTON, CA.—February 12, 2018—10x Genomics, Inc., a company focused on accelerating genomic discovery, today announced a global partnership ecosystem to accelerate customer adoption of 10x Genomics’ sequencing applications through the Certified Service Provider... Read more